Tag: BRUKINSA

Home / BRUKINSA

Categories

Zanubrutinib is approved by FDA for chronic lymphocytic leukemia or small lymphocytic lymphoma

Feb 2023: Zanubrutinib (Brukinsa, BeiGene USA, Inc.) is approved by FDA for chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). SEQUOIA was used to assess effectiveness in CLL/...
brukinsa

Scan the code